US Congress report says FDA approved Mifeprex properly
This article was originally published in Scrip
Executive Summary
A new report by the USGovernment Accountability Office, Congress's investigative arm, claims that the USFDA's approval and oversight of Danco Laboratories' abortifacient, Mifeprex (mifepristone, also known as RU-486), was properly handled. Some believe this will put an end to any argument that special treatment was given during the approval process.